MedPath

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH

Early Phase 1
Completed
Conditions
Postpartum Hemorrhage
High Risk Pregnancy
Cesarean Section
Interventions
Registration Number
NCT04089176
Lead Sponsor
Rajavithi Hospital
Brief Summary

Objective: study efficacy of carbtocin versus oxytocin for prevention postpartum hemorrhage in high risk pregnancy who undergo cesarean section

Detailed Description

Randomized controlled clinical trial. Defined patient in two group. Primary outcome is evaluate additional drug use Secondary outcome is evaluated estimated blood loss, hemoglobin level

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • previous history of postpartum hemorrhage
  • polyhydramnios
  • fetal macrosomia
  • previous cesarean section
  • grand multiparity
  • intramural myoma
  • chorioamnionitis
  • prolonged premature rupture of membrane
  • augmentation of labour
Exclusion Criteria
  • pregnancy induce hypertension
  • on anticoagulant
  • placenta previa or placenta percreta

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
protocal ACarbetocinCarbetocin versus placebo
protocal BoxytocinOxytocin versus placebo
protocal AoxytocinCarbetocin versus placebo
protocal BCarbetocinOxytocin versus placebo
Primary Outcome Measures
NameTimeMethod
Additional drug useduring intra-operation

Number of additional drug use after intervention drug

Secondary Outcome Measures
NameTimeMethod
Side effectDuring intra-opeartion and acute post operation period as 24 hours post operation

type of side effect

Estimate blood lossDuring intra-opeartion and acute post operation period as 24 hours post operation

amount of blood loss

Hemoglobin levelPre-operation and 24 hours post operation

differentiation of hemoglobin

Trial Locations

Locations (1)

Rajavithi Hospital

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath